Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic, Sumitomo Renew and Expand Licensing Agreement

NEW YORK, Jan. 8 (GenomeWeb News) - Sumitomo Pharmaceuticals has renewed its agreement with Gene Logic to use the gene-expression data in Gene Logic's BioExpress database, the companies said today.


The companies signed the original agreement exactly three years ago.


The new agreement, which includes access to Gene Logic's ToxScreen and Mechanism of Toxicity systems, also gives Sumitomo limited-seat access to Gene Logic's newer ASCENTA system.  

Financial details of the three-year agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.